-
Je něco špatně v tomto záznamu ?
TAp73 and ΔTAp73 isoforms show cell-type specific distributions and alterations in cancer
V. Hrabal, M. Stenckova, F. Zavadil Kokas, P. Muller, R. Nenutil, B. Vojtesek, PJ. Coates
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
MMCI 00209805
Ministerstvo Zdravotnictví Ceské Republiky
GACR 23-05951S
Grantová Agentura České Republiky
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
- MeSH
- epitelové buňky metabolismus MeSH
- lidé MeSH
- monoklonální protilátky MeSH
- nádorové buněčné linie MeSH
- nádory děložního čípku metabolismus patologie genetika MeSH
- nádory metabolismus patologie genetika MeSH
- protein - isoformy * metabolismus genetika MeSH
- protein p73 * metabolismus genetika MeSH
- spinocelulární karcinom metabolismus patologie genetika MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
TP73 is a member of the TP53 gene family and produces N- and C-terminal protein isoforms through alternative promoters, alternative translation initiation and alternative splicing. Most notably, p73 protein isoforms may either contain a p53-like transactivation domain (TAp73 isoforms) or lack this domain (ΔTAp73 isoforms) and these variants have opposing or independent functions. To date, there is a lack of well-characterised isoform-specific p73 antibodies. Here, we produced polyclonal and monoclonal antibodies to N-terminal p73 variants and the C-terminal p73α isoform, the most common variant in human tissues. These reagents show that TAp73 is a marker of multiciliated epithelial cells, while ΔTAp73 is a marker of non-proliferative basal/reserve cells in squamous epithelium. We were unable to detect ΔNp73 variant proteins, in keeping with recent data that this is a minor form in human tissues. Most cervical squamous cell carcinomas (79%) express p73α, and the distribution of staining in basal cells correlated with lower tumour grade. TAp73 was found in 17% of these tumours, with a random distribution and no association with clinicopathological features. These data indicate roles for ΔTAp73 in maintaining a non-proliferative state of undifferentiated squamous epithelial cells and for TAp73 in the production of differentiated multiciliated cells.
Department of Experimental Biology Faculty of Science Masaryk University Brno Czech Republic
Department of Pathology Masaryk Memorial Cancer Institute Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003111
- 003
- CZ-PrNML
- 005
- 20250206104039.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-024-80927-9 $2 doi
- 035 __
- $a (PubMed)39622910
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hrabal, Vaclav $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic. vaclav.hrabal@mou.cz $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. vaclav.hrabal@mou.cz
- 245 10
- $a TAp73 and ΔTAp73 isoforms show cell-type specific distributions and alterations in cancer / $c V. Hrabal, M. Stenckova, F. Zavadil Kokas, P. Muller, R. Nenutil, B. Vojtesek, PJ. Coates
- 520 9_
- $a TP73 is a member of the TP53 gene family and produces N- and C-terminal protein isoforms through alternative promoters, alternative translation initiation and alternative splicing. Most notably, p73 protein isoforms may either contain a p53-like transactivation domain (TAp73 isoforms) or lack this domain (ΔTAp73 isoforms) and these variants have opposing or independent functions. To date, there is a lack of well-characterised isoform-specific p73 antibodies. Here, we produced polyclonal and monoclonal antibodies to N-terminal p73 variants and the C-terminal p73α isoform, the most common variant in human tissues. These reagents show that TAp73 is a marker of multiciliated epithelial cells, while ΔTAp73 is a marker of non-proliferative basal/reserve cells in squamous epithelium. We were unable to detect ΔNp73 variant proteins, in keeping with recent data that this is a minor form in human tissues. Most cervical squamous cell carcinomas (79%) express p73α, and the distribution of staining in basal cells correlated with lower tumour grade. TAp73 was found in 17% of these tumours, with a random distribution and no association with clinicopathological features. These data indicate roles for ΔTAp73 in maintaining a non-proliferative state of undifferentiated squamous epithelial cells and for TAp73 in the production of differentiated multiciliated cells.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a protein p73 $x metabolismus $x genetika $7 D000072160
- 650 12
- $a protein - isoformy $x metabolismus $x genetika $7 D020033
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a spinocelulární karcinom $x metabolismus $x patologie $x genetika $7 D002294
- 650 _2
- $a nádory děložního čípku $x metabolismus $x patologie $x genetika $7 D002583
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a epitelové buňky $x metabolismus $7 D004847
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a nádory $x metabolismus $x patologie $x genetika $7 D009369
- 650 _2
- $a monoklonální protilátky $7 D000911
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Stenckova, Michaela $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic
- 700 1_
- $a Zavadil Kokas, Filip $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic
- 700 1_
- $a Muller, Petr $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic
- 700 1_
- $a Nenutil, Rudolf $u Department of Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Vojtesek, Borivoj $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic
- 700 1_
- $a Coates, Philip J $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic. philip.coates@mou.cz
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 14, č. 1 (2024), s. 29949
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39622910 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104035 $b ABA008
- 999 __
- $a ok $b bmc $g 2263082 $s 1239118
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 14 $c 1 $d 29949 $e 20241202 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- GRA __
- $a MMCI 00209805 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a GACR 23-05951S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20250121